| |
|
|
| The Supreme Court has agreed to hear an appeal by Merck & Co. that seeks to halt a lawsuit accusing the drugmaker of defrauding investors about the dangers posed by the withdrawn painkiller Vioxx. The appeal hinges on whether investors filed the lawsuit within a two-year period from when evidence of alleged fraud first appeared. The 3rd Circuit Court of Appeals had previously ruled that the class action was filed within the two-year window. Greg Stohr, Bloomberg 05/26/2009 |
| Read Article: Bloomberg |

0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home